超重倾向于微血管阻塞:来自TATORT-NSTEMI试验的见解
Felix Troger1, Ingo Eitel2,3, Roza Saraei2,3
1University Clinic of Radiology, Medical University of Innsbruck, Innsbruck, Austria.
The international journal of cardiovascular imaging
|January 18, 2026
概括
较高的体重指数 (BMI) 与非ST升高心肌梗塞 (NSTEMI) 后的微血管阻塞 (MVO) 有关. 超重患者,特别是BMI超过25.6kg/m2的患者,MVO增加,挑战了肥胖悖论.
科学领域:
- 心脏病学 心脏病学
- 医疗成像医学成像
- 临床研究 临床研究
背景情况:
- 微血管阻塞 (MVO) 对急性心肌梗塞后的结果产生负面影响.
- 之前的研究表明,增加的体重指数 (BMI) 对ST升高心肌梗塞 (STEMI) 中的MVO具有保护作用.
- 关于超重和MVO在非ST升高心肌梗塞 (NSTEMI) 中的发展之间的关联存在有限的数据.
研究的目的:
- 调查NSTEMI患者的BMI和MVO发生之间的关系.
- 确定超重是否是NSTEMI中MVO的独立预测因素.
- 探索这个患者群体中"肥胖悖论"的含义.
主要方法:
- 来自TATORT-NSTEMI试验的子队列的分析,包括354名NSTEMI患者.
- 心脏磁共振成像 (CMR) 在指数事件发生后四天内进行,以评估MVO.
- 统计分析,包括后勤回归,以评估BMI和MVO之间的关联,调整心血管风险因素.
主要成果:
- 在27%的患者中存在MVO.
- 与没有MVO (27.3 kg/m2) 患者相比,MVO患者的BMI中位数显著更高 (28.4 kg/m2).
- 超过25.6公斤/平方米的BMI被确定为NSTEMI患者中MVO的显著独立预测因素,在33%的病例中观察到,而在较低BMI组中则为15%.
结论:
- 增加的BMI与NSTEMI患者中MVO的可能性更高有关.
- 超重,定义为BMI>25.6 kg/m2,独立预测MVO,与"肥胖悖论"在这种情况下相矛盾.
- 需要进一步的研究,以阐明心肌梗塞中体重和微血管损伤之间的复杂相互作用.
相关概念视频
03:05Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
492
This protocol details the acupuncture procedures for patients with overweight complicated by hyperlipidemia and certifies the influence of emotional factors on therapeutic efficacy based on metrics including BMI, cholesterol, and triglyceride...
492
10:00Quantifying Pulmonary Microvascular Density in Mice Across Lobules
4.1K
Here, we describe a simple and economical protocol to perform unbiased quantification of pulmonary microvascular density for whole mice lung tissue using single staining of Isolectin...
4.1K
01:16Clinical Trials
10.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.2K
01:11Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
01:12Trial and Error and Algorithm
398
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
398
04:37Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis
1.4K
This protocol describes a method for inducing unilateral ureteral obstruction (UUO) in mice to study the progression of tissue fibrosis in obstructive nephropathy. It includes surgical procedures, post-operative care, and methods for fibrosis...
1.4K